Lam S

ORCID: 0000-0002-3964-1492 · 2 papers in corpus
2022
Journal of Clinical Oncology ·doi:10.1200/jco.21.01460

PurposeTo investigate whether a panel of circulating protein biomarkers would improve risk assessment for lung cancer screening in combination with a risk model on the basis of participant characteristics.MethodsA blinded validation study w…

2022
Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol29070368

Individuals with proven hereditary cancer syndrome (HCS) such as BRCA1 and BRCA2 have elevated rates of ovarian, breast, and other cancers. If these high-risk people can be identified before a cancer is diagnosed, risk-reducing intervention…